Historically, the United States was at the forefront of surgical discovery, as measured by publications and citations.
Methods | The tables of contents of the top 10 impact factorranked, non-subspecialty surgical journals were searched for RCTs published from January 1, 2003 , to December 31, 2005 , and from January 1, 2013, to December 31, 2015 and categorized by clinical focus and country origin. This study did not meet the criteria for institutional review board review as it did not involve human subjects research and used publicly available, published manuscripts. Data were collected from February 1, 2017, to June 1, 2017. Data analysis took place from June 1, 2017, to July 1, 2017.
Two of us (J.A.F. and S.M.W.) independently classified the trials into 12 categories on the basis of a clinical end point. Country of origin was defined by the study population or by the senior authors' nationality. Trials after 2005 were excluded if they were not registered in a mandatory public trials registry acceptable to the International Committee of Medical Journal Editors. 4 Trials by country were normalized to the number per 100 000 population and to the amount of government-only gross domestic spending on research and development (R&D). [5] [6] [7] These ratios are proxy measurements for an individual country's rate of publication and the efficiency of government spending on surgical R&D. (Table) .
Discussion | Randomized clinical trials require substantial financial and organizational investment. Historically, the United States excelled in its capacity and influence in surgery. Although it remains the world leader in overall number of surgical RCTs published, it has stagnated and is now behind most of Western Europe in per capita publications. Of concern, especially in the United States, is a global trend toward a decreased number of surgery RCTs per government R&D investment. Influencers of this trend could include the diminished allocation of research dollars to surgery or the inefficiencies in translating funding into publications. The inefficiency of surgical RCTs is a concern; a third of RCTs remain unpublished, and 20% of trials are discontinued at 5 years, most commonly owing to insufficient patient recruitment. 3 It was not possible to determine causation in this analysis. Regardless, action and intervention are necessary to ensure continued government funding and to improve the efficiency of RCTs so that they are published. Published surgical research is essential for improving surgical practice and increasingly must be accomplished in financially constrained environments. As a surgical community, we must critically analyze and improve the use of research investments. The rate of nonpublication and the amount of trial discontinuations due to insufficient patient recruitment highlight a poor functioning system. If the United States wants to regain its preeminence in surgical research, prompt action is necessary to improve dedicated surgical RCT funding and to transform the US surgical research system into one designed for efficiency. 
